Monsanto said that its full-year 2008 EPS guidance, both on a reported and ongoing basis, is in the range of $2.20 to $2.40. The company's 2008 EPS guidance reflects a projected growth rate of 10 percent to 20 percent from the fiscal year 2007 EPS ongoing base of $2.00 per share.
The company also confirmed guidance for free cash flow for fiscal year 2008 will be in the range of $800 million to $900 million. The company expects net cash provided by operating activities to be in the range of $1.75 billion to $1.85 billion, and net cash required by investing activities to be approximately $950 million for fiscal year 2008. (For a reconciliation of free cash flow, see note 2.)
Monsanto also noted that it expects that SG&A expense as a percent of sales for fiscal year 2008 will be in the range of 20 percent to 21 percent. The company also confirmed that its R&D expenses as a percent of sales for fiscal year 2008 are expected to be approximately 10 percent.
Trait Acreage Report
As part of today's announcement, Monsanto published its year-end report on the company's biotech trait acreage for fiscal year 2007. This report is available on Monsanto's web site at: http://www.monsanto.com/monsanto/layout/investor/company/crop.asp.
Seeds and Genomics Segment Detail
($ in millions) Net Sales Gross Profit
Fourth Fourth Fiscal Fiscal Fourth Fourth Fiscal Fiscal
Seeds and Quarter Quarter Year Year Quarter Quarter Year Year
Genomics 2007 2006 2007 2006 2007 2006 2007 2006
and traits $364 $212 $2,807 $1,793 $178 $71 $1,721 $1,019
and traits 33 27 901 960 7 12 588 667
and traits 58 52 31
Copyright©2007 PR Newswire.
All rights reserved